Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ANPCY NASDAQ:BIAFW OTCMKTS:EPGNY OTCMKTS:WUXAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANPCYANGLEC$0.79-0.6%C$0.83C$0.61▼C$2.39N/AN/A1,271 shs607 shsBIAFWbioAffinity Technologies$0.07+14.9%$0.14$0.05▼$2.49N/AN/A10,671 shs194 shsEPGNYEpigenomics$2.39$2.39$2.01▼$2.39N/AN/A100 shsN/AWUXAYWuXi AppTec$13.01-0.2%$11.59$4.06▼$15.10N/AN/A10,937 shs239,899 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANPCYANGLE0.00%+28.50%-8.68%-28.18%-53.53%BIAFWbioAffinity Technologies0.00%-30.50%-66.90%-46.54%-96.49%EPGNYEpigenomics0.00%0.00%0.00%0.00%0.00%WUXAYWuXi AppTec0.00%-2.91%+5.77%+56.94%+213.49%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANPCYANGLEN/AN/AN/AN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANPCYANGLE 0.00N/AN/AN/ABIAFWbioAffinity Technologies 0.00N/AN/AN/AEPGNYEpigenomics 0.00N/AN/AN/AWUXAYWuXi AppTec 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANPCYANGLEN/AN/AN/AN/AN/AN/ABIAFWbioAffinity Technologies$7.68MN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANPCYANGLEN/A-C$0.48N/A∞N/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/AEPGNYEpigenomicsN/A-$3.05N/A∞N/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/A0.00∞N/AN/AN/AN/A10/27/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANPCYANGLEN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AEPGNYEpigenomicsN/AN/AN/AN/AN/AWUXAYWuXi AppTecN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AWUXAYWuXi AppTecN/AInsider OwnershipCompanyInsider OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/AEPGNYEpigenomicsN/AWUXAYWuXi AppTecN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANPCYANGLE173N/AN/ANot OptionableBIAFWbioAffinity Technologies10N/AN/ANot OptionableEPGNYEpigenomics32N/AN/ANot OptionableWUXAYWuXi AppTec41,116N/AN/ANot OptionableWUXAY, ANPCY, BIAFW, and EPGNY HeadlinesRecent News About These CompaniesShort Interest in WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Grows By 718.2%August 16, 2025 | americanbankingnews.comChina's Wuxi Apptec to raise over $980 million to boost expansionJuly 30, 2025 | reuters.comWuXi AppTec Adjusts Share Repurchase Price Limit Amid Rising Share ValueJuly 29, 2025 | tipranks.comWuXi AppTec Shares Rise After Raising Full-Year GuidanceJuly 29, 2025 | marketwatch.comWuXi AppTec Reports Robust Financial Growth in H1 2025July 28, 2025 | tipranks.comWuXi AppTec Schedules Board Meeting to Review Interim ResultsJuly 14, 2025 | tipranks.comWuXi AppTec Issues Positive Profit Alert for the First Half of 2025July 10, 2025 | prnewswire.comWuXi AppTec Projects Significant Profit Growth for H1 2025July 10, 2025 | tipranks.comWuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition ActivitiesJuly 7, 2025 | prnewswire.comWuXi AppTec Completes HK$1 Billion H Share Acquisition for Employee Incentive SchemeJune 30, 2025 | tipranks.comWuXi AppTec wins Architizer A Award for Nantong site designJune 27, 2025 | msn.comWuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and HumanityJune 26, 2025 | prnewswire.comWuXi AppTec-Backed MegaRobo Is Said to Plan Hong Kong IPOJune 25, 2025 | bloomberg.comWuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction TargetsJune 17, 2025 | prnewswire.comWuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top HonorsJune 16, 2025 | prnewswire.comWuXi AppTec Adjusts Conversion Price of Convertible BondsMay 23, 2025 | tipranks.comWuXi AppTec Adjusts Share Repurchase Price Limits Amid Dividend DistributionsMay 14, 2025 | tipranks.comWuXi AppTec Co., (WUXIF) Ltd. Q1 2025 Earnings Call TranscriptApril 29, 2025 | seekingalpha.comMendota Heights med tech company to lay off 124 workers after acquisitionApril 8, 2025 | twincities.comTWuXi AppTec's Changzhou and Taixing API Sites Successfully Pass FDA InspectionsMarch 31, 2025 | finance.yahoo.comMedia Sentiment Over TimeWUXAY, ANPCY, BIAFW, and EPGNY Company DescriptionsANGLE OTCMKTS:ANPCYC$0.79 -0.01 (-0.63%) As of 08/22/2025 03:36 PM EasternANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.bioAffinity Technologies NASDAQ:BIAFW$0.07 +0.01 (+14.88%) As of 08/22/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.Epigenomics OTCMKTS:EPGNY$2.39 0.00 (0.00%) As of 04/6/2023Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.WuXi AppTec OTCMKTS:WUXAY$13.01 -0.02 (-0.15%) As of 08/22/2025 03:48 PM EasternWuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access